Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
02-Jun-2025 | 524.6 | 524.8 | 512 | 518.15 | 4,675 | 5,82,84,272.4 | 51,346 |
03-Jun-2025 | 519 | 523.95 | 513.2 | 520.25 | 3,275 | 6,59,53,290.9 | 72,088 |
04-Jun-2025 | 520 | 523 | 510.25 | 515.4 | 4,277 | 4,87,07,013.15 | 46,655 |
05-Jun-2025 | 516.9 | 536 | 512.75 | 525.75 | 9,738 | 13,38,39,567.45 | 1,17,725 |
06-Jun-2025 | 528.2 | 541.95 | 521.3 | 532.9 | 13,394 | 20,69,73,503.1 | 1,08,925 |
09-Jun-2025 | 536 | 540 | 530 | 535.05 | 8,366 | 12,29,30,599.35 | 71,366 |
10-Jun-2025 | 536.9 | 546 | 529.1 | 542.05 | 9,740 | 13,38,35,112.5 | 99,930 |
11-Jun-2025 | 542.05 | 553.9 | 538.15 | 542.1 | 11,481 | 15,39,79,510.15 | 1,15,808 |
12-Jun-2025 | 547 | 564 | 539.1 | 546.15 | 16,718 | 23,28,69,682 | 1,61,484 |
13-Jun-2025 | 535.05 | 561 | 534 | 556.95 | 16,648 | 24,47,51,103 | 1,98,235 |
16-Jun-2025 | 560 | 564.8 | 543.05 | 557.35 | 10,617 | 12,21,94,404.7 | 84,953 |
17-Jun-2025 | 559.4 | 559.4 | 531 | 534.5 | 10,996 | 12,55,53,634.8 | 1,32,735 |
18-Jun-2025 | 531 | 542 | 530.1 | 532.5 | 6,862 | 6,58,55,091.6 | 48,825 |
19-Jun-2025 | 535.7 | 537.05 | 513 | 518.6 | 7,879 | 6,33,01,506.8 | 52,194 |
20-Jun-2025 | 518.6 | 524.85 | 515.2 | 520.15 | 6,635 | 4,15,75,976.75 | 30,213 |
23-Jun-2025 | 520 | 529.65 | 515 | 523.85 | 6,444 | 5,44,19,546.4 | 41,934 |
24-Jun-2025 | 525 | 536 | 522.1 | 530.85 | 5,937 | 5,96,28,797.55 | 47,631 |
25-Jun-2025 | 532 | 574.95 | 532 | 571.9 | 28,623 | 40,22,93,064.65 | 3,74,554 |
26-Jun-2025 | 576 | 580 | 553.65 | 573 | 21,380 | 24,46,14,106.9 | 1,55,613 |
27-Jun-2025 | 575 | 577 | 563.05 | 568.2 | 9,989 | 11,70,81,870.65 | 74,656 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
